C18H34ClN2O8PS
Neat
505.0
Clindamycin 4-Phosphate; CSQ77RZL4N; 54887-30-8; UNII-CSQ77RZL4N; Clindamycin phosphate impurity D [EP]; [(2R, 3R, 4R, 5R, 6R)-2-[(1S, 2S)-2-chloro-1-[[(2S, 4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4, 5-dihydroxy-6-methylsulfanyloxan-3-yl] dihydrogen phosphate; Methyl 7-chloro-6, 7, 8-trideoxy-6-((((2S, 4R)-1-methyl-4-propylpyrrolidin-2-yl)carbonyl)amino)-4-o-PHOSPHONO-1-thio-L-threo-alpha-D-galacto-octopyranoside; Clindamycin Phosphate EP Impurity D; Clindamycin Phosphas EP Impurity D; (2R, 3R, 4R, 5R, 6R)-2-((1S, 2R)-2-chloro-1-((2S, 4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4, 5-dihydroxy-6-(methylthio)tetrahydro-2H-pyran-3-yl dihydrogen phosphate; CLINDAMYCIN PHOSPHATE IMPURITY D [EP IMPURITY]; (2R, 3R, 4R, 5R, 6R)-2-((1S, 2S)-2-chloro-1-((2S, 4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4, 5-dihydroxy-6-(methylthio)tetrahydro-2H-pyran-3-yl dihydrogen phosphate; METHYL 7-CHLORO-6, 7, 8-TRIDEOXY-6-((((2S and 4R)-1-METHYL-4-PROPYLPYRROLIDIN-2-YL)CARBONYL)AMINO)-4-O-PHOSPHONO-1-THIO-L-THREO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE
[(2R, 3R, 4R, 5R, 6R)-2-[(1S, 2S)-2-chloro-1-[[(2S, 4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4 and 5-dihydroxy-6-methylsulfanyloxan-3-yl] dihydrogen phosphate
InChI=1S/C18H34ClN2O8PS/c1-5-6-10-7-11(21(3)8-10)17(24)20-12(9(2)19)15-16(29-30(25,26)27)13(22)14(23)18(28-15)31-4/h9-16,18,22-23H,5-8H2,1-4H3,(H,20,24)(H2,25,26,27)/t9-,10+,11-,12+,13+,14+,15+,16+,18+/m0/s1